Vitafoods Europe 2024: Givaudan reveals new clinical research on Pacran’s urinary tract health benefits
06 Jun 2024 | Givaudan
Dan Souza, global product manager for branded ingredients at Givaudan, detailed the latest clinical trial results supporting the efficacy and reliability of Pacran, the company’s cranberry ingredient for urinary tract health. The research confirmed earlier findings, revealing that 500 mg of Pacran daily could reduce recurrent urinary tract infections and improve other urinary tract health indicators. Souza also indicated upcoming studies in different health areas, such as mind and energy, physical health, gut health and intimate health.
More videos